The European Society of Cardiology has issued its first joint guidelines with the European Renal Association to address the dangerous interplay between cardiovascular disease and chronic kidney disease. Published at ESC Congress 2026, the framework introduces the STAMP strategy to improve screening and cross-specialty coordination for millions of at-risk patients.
The Dangerous Interplay Between Heart and Kidney Disease
Chronic kidney disease and cardiovascular disease operate in a destructive feedback loop. When kidney function declines, it accelerates cardiovascular complications, while heart failure or vascular damage in turn impairs renal health. An estimated 100 million people across Europe live with chronic kidney disease, defined as persistent structural or functional kidney abnormalities lasting at least three months. This heavy burden makes the intersection of these two conditions a major public health challenge.
On a global scale, cardiovascular disease remains the leading cause of death, while the American Heart Association estimates that approximately 92.1 million American adults live with some form of heart disease or stroke after-effects. When kidney disease enters the picture, the vulnerability multiplies. The National Institute of Diabetes and Digestive and Kidney Diseases notes that heart disease is the most common cause of death among people who have kidney disease, largely due to this accelerated cardiovascular toll.
Shared Drivers: Diabetes and High Blood Pressure
The overlap between cardiac and renal deterioration stems largely from common roots. Diabetes and high blood pressure act as the two primary catalysts for both conditions, systematically damaging delicate blood vessels throughout the body.
Excess blood glucose over time compromises both heart muscle and renal filtration units. Simultaneously, high blood pressure forces the heart to pump harder while injuring the small blood vessels inside the kidneys. This creates a self-perpetuating trap where damaged kidneys fail to filter extra water and salt, driving blood pressure higher and further accelerating renal decline.
The STAMP on CKD Strategy for Early Screening
To interrupt this cycle, the new guidelines establish an organizational framework known by the acronym STAMP: Screen, Triage, Address CKD Risk, Modify CVD management, and Plan health services. Screening forms the cornerstone of the initiative. The guidelines advise testing every patient diagnosed with cardiovascular disease for chronic kidney disease using a combination of blood creatinine measurements and urine albumin-to-creatinine ratios.
Many patients with CKD are treated by the cardiology community and the new ESC Guidelines aim to increase the use of kidney function and urine albumin testing in patients with CVD.
Professor William Herrington, Task Force Chair from the University of Oxford, UK
Following screening, triage uses validated risk scoring tools that factor in kidney function to gauge a patient’s exact risk of progressing to kidney failure or experiencing a cardiovascular event. This precise stratification ensures that care teams catch high-risk individuals before advanced symptoms appear.
Targeted Therapies and Medication Adjustments
Addressing risk early allows clinicians to deploy proven pharmacotherapies designed to slow disease progression and prevent heart complications. Medical management relies heavily on specific classes of pharmaceuticals administered alongside standard lipid-lowering regimens.
Beyond introducing protective medications, the guidelines published in the European Heart Journal emphasize adjusting standard cardiovascular treatments for patients whose renal clearance is compromised. Because reduced kidney function alters how the body processes pharmaceutical agents, the recommendations specify which alternative treatments can be utilized safely.
Coordinating Care Across Specialties
Because patients with overlapping cardiac and renal conditions often bounce between cardiology and nephrology wards, the final pillar of the strategy focuses on health service planning and multidisciplinary communication.
The framework also incorporates patient and caregiver engagement to align treatment plans with personal priorities and improve overall care experiences. Alongside the professional guidelines, a dedicated patient version has been released to help individuals understand their diagnoses and participate directly in shared clinical decisions.
